Abstract
Hyperkalemia in young children is a rare phenomenon and in many cases caused by hemolysis in the specimen due to difficulties in obtaining a sample. However, hyperkalemia can also be a sign of a rare Mendelian syndrome known as familial hyperkalemic hypertension or pseudohypoaldosteronism type II. This disease is characterized by hyperkalemia, hypertension, and mild hyperchloremic metabolic acidosis (with normal anion gap) despite normal glomerular filtration. Full recovery of these abnormalities with thiazide diuretics is essential not to miss the diagnosis of this syndrome. We describe two young patients with hyperkalemia as an incidental finding who were subsequently diagnosed with this rare endocrine disorder. Genetic testing revealed mutations in two recently discovered genes, the study of which has helped to unravel the pathophysiologic pathways.
Conclusion: In patients with hyperkalemia and a normal glomerular filtration rate, the clinician should actively search for abnormalities in blood pressure since recognizing this condition can lead to simple, cheap, and effective treatment.
What is Known: • True Hyperkalemia is rare in pediatrics and can be a sign of FHHt. |
What is New: • KLHL3 & CUL3 are recently discovered genes helping unravel the pathophysiologic pathway of FHHt. |
Abbreviations
- FHHt:
-
Familial hyperkalemic hypertension
- PHAII:
-
Pseudohypoaldosteronism type II
- WNK1:
-
With-no-lysine[K] kinase 1
- WNK4:
-
With-no-lysine[K] kinase 4
- KLHL3:
-
Kelch-like 3
- CUL3:
-
Cullin 3
- NCC:
-
Sodium chloride cotransporter
- ROMK:
-
Renal outer medullary K+ channel
References
Boyden LM, Choi M, Choate KA, Nelson-Williams CJ, Farhi A, Toka HR, Tikhonova IR, et al. (2012) Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482:98–102
Gordon RD (1986) Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 8:93–102
Hadchouel J, Ellison DH, Gamba G (2016) Regulation of renal electrolyte transport by WNK and SPAK-OSR1 kinases. Annu Rev Physiol 78:367–389
Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, et al. (2012) KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet 44:456–460, S451–453
Pereira-Mestre R, Giannini O, Manzocchi V, Bianchetti MG (2012) Masked hypertension delaying diagnosis in Gordon’s syndrome. J Hypertens 30:2240
Schmidt ATD, Bael A, Wojciechowski M, Van Hoeck K (2007) Persistent potassium disorders, in infancy: symptomless but serious. Tijdschrift Belgische Kinderarts 9:40–42
Xie J, Craig L, Cobb MH, Huang CL (2006) Role of with-no-lysine [K] kinases in the pathogenesis of Gordon’s syndrome. Pediatr Nephrol 21:1231–1236
Authors’ Contributions
RH wrote the paper. GM supervised the genetic part as well as editor for the entire text. KVH was the main promoter of the project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
For this type of paper formal consent is not required.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Communicated by Mario Bianchetti
Rights and permissions
About this article
Cite this article
Hollander, R., Mortier, G. & van Hoeck, K. Hyperkalemia in young children: blood pressure checked?. Eur J Pediatr 175, 2011–2013 (2016). https://doi.org/10.1007/s00431-016-2782-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-016-2782-y